Attractor – a new turning point in drug discovery

References

• Kauffman SA. The Origins of Order: Self-Organization and Selection in Evolution. New York: New York Oxford University Press; 1993.
   Google Scholar
• Li F, Long T, Lu Y, Ouyang Q, Tang C. The yeast cell-cycle network is robustly designed. Proc Natl Acad Sci USA. 2004;101(14):4781–4786. doi:10.1073/pnas.030593710115037758
   PubMed Web of Science ®Google Scholar
• Huang S. Cell fates as attractors: stability and flexibility of cellular phenotypes In: Aird WC, editor. Endothelial Biomedicine. Cambridge: Cambridge University Press; 2007;1767–1779.
   Google Scholar
• Cho SH, Park SM, Lee HS, Lee HY, Cho KH. Attractor landscape analysis of colorectal tumorigenesis and its reversion. BMC Syst Biol. 2016;10(1):96. doi:10.1186/s12918-016-0304-127765040
   PubMed Web of Science ®Google Scholar
• Zañudo JG, Albert R. Cell fate reprogramming by control of intracellular network dynamics. PLoS Comput Biol. 2015;11(4):e1004193. doi:10.1371/journal.pcbi.100419325849586
   PubMed Web of Science ®Google Scholar
• Huang S, Ernberg I, Kauffman S. Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol. 2009;20(7):869–876. doi:10.1016/j.semcdb.2009.07.00319595782
   PubMed Web of Science ®Google Scholar
• Huang S, Kauffman S. How to escape the cancer attractor: rationale and limitations of multi-target drugs. Semin Cancer Biol. 2013;23(4):270–278. doi:10.1016/j.semcancer.2013.06.00323792873
   PubMed Web of Science ®Google Scholar
• Zhang DZ. Introduction to Pharmacy. 4th ed. Beijing: China Medical Science Press; 2011.
   Google Scholar
• Nie SF, Li JW, Wang XD. Drug Discovery and Invention History. 1st ed. Shanghai: Shanghai Second Military Medical University Press; 2013.
   Google Scholar
• Fischer E. Einflus der Configuration auf die Wirkung der Enzyme [Influence of the configuration on the action of the enzymes]. Eur J Inorg Chem. 2010;27(3):2985–2993. German.
   Google Scholar
• Maehle AH, Prüll CR, Halliwell RF. The emergence of the drug receptor theory. Nat Rev Drug Discov. 2002;1(8):637–641. doi:10.1038/nrd87512402503
   PubMed Web of Science ®Google Scholar
• Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol. 1948;153(3):586–600. doi:10.1152/ajplegacy.1948.153.3.58618882199
   PubMed Web of Science ®Google Scholar
• Zhao J. Advances in multi-target and multi-component drug research based on systems biology. Beijing Chin Pharm J. 2010;45(15):1121–1126. Chinese.
   Google Scholar
• Medina-Franco JL, Giulianotti MA, Welmaker GS, Houghten RA. Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today. 2013;18(9–10):495–501. doi:10.1016/j.drudis.2013.01.00823340113
   PubMed Web of Science ®Google Scholar
• Collis MC. Integrative pharmacology and drug discovery-is the tide finally turning?. Nat Rev Drug Discov. 2006;5(5):377–379. doi:10.1038/nrd203616628199
   PubMed Web of Science ®Google Scholar
• Maggiora GM. The reductionist paradox: are the laws of chemistry and physics sufficient for the discovery of new drugs? J Comput Aided Mol Des. 2011;25(8):699–708. doi:10.1007/s10822-011-9447-821698487
   PubMed Web of Science ®Google Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004;3(8):711–715. doi:10.1038/nrd147015286737
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for drug discovery and exploration. Nucleic Acids Res. 2006;34(Database issue):D668–D672. doi:10.1093/nar/gkj06716381955
   PubMed Web of Science ®Google Scholar
• Talevi A. Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective. Front Pharmacol. 2015;6:205. doi:10.3389/fphar.2015.0020526441661
   PubMed Web of Science ®Google Scholar
• Van Regenmortel MH. Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism. EMBO Rep. 2004;5(11):1016–1020. doi:10.1038/sj.embor.740028415520799
   PubMed Web of Science ®Google Scholar
• Petrelli A.  Polypharmacological kinase inhibitors: new hopes for cancer therapy In: Peters J-U, editor. Polypharmacology in Drug Discovery. New Jersey: John Wiley & Sons, Inc.; 2012;149–165.
   Google Scholar
• Azmi AS. Network pharmacology for cancer drug discovery: are we there yet? Future Med Chem. 2012;4(8):939–941. doi:10.4155/fmc.12.4422650234
   PubMed Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25(10):1110–1111. doi:10.1038/nbt1007-111017921993
   PubMed Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.11818936753
   PubMed Web of Science ®Google Scholar
• Kitano H. Biological robustness. Nat Rev Genet. 2004;5(11):826–837. doi:10.1038/nrg147115520792
   PubMed Web of Science ®Google Scholar
• Zhao J, Yu H, Luo JH, Cao ZW, Li YX. Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics. 2006;7:386. doi:10.1186/1471-2105-7-38616916470
   PubMed Web of Science ®Google Scholar
• Zhao J, Tao L, Yu H, Luo JH, Cao ZW, Li YX. Bow-tie topological features of metabolic networks and the functional significance. Beijing Chin Sci Bull. 2007;52(8):1036–1045.
   Web of Science ®Google Scholar
• Jeong H, Mason SP, Barabási AL, Oltvai ZN. Lethality and centrality in protein networks. Nature. 2001;411(6833):41–42. doi:10.1038/3507513811333967
   PubMed Web of Science ®Google Scholar
• Zhao J, Geng C, Tao L, et al. Reconstruction and analysis of human liver-specific metabolic network based on CNHLPP data. J Proteome Res. 2010;9(4):1648–1658. doi:10.1021/pr900618820136149
   PubMed Web of Science ®Google Scholar
• Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. Drug-target network. Nat Biotechnol. 2007;25(10):1119–1126. doi:10.1038/nbt133817921997
   PubMed Web of Science ®Google Scholar
• Thieffry D, Thomas R. Dynamical behaviour of biological regulatory networks–II. Immunity control in bacteriophagelambda. Bull Math Biol. 1995;57(2):277–297. doi:10.1016/0092-8240(94)00037-D7703921
   PubMed Web of Science ®Google Scholar
• Somogyi R, Sniegoski CA. Modeling the complexity of genetic networks: understanding multigenic and pleiotropic regulation. Complexity. 1996;1(6):45–63. doi:10.1002/cplx.v1.6
   Google Scholar
• Liu LL. Research on dynamic behavior of boolean networks [dissertation]. Zhejiang: University of Wen Zhou; 2012 Chinese.
   Google Scholar
• Hu MX. Research on optimal bit intervention algorithm based on boolean network attraction domain [dissertation]. Zhjiang: University of Wen Zhou; 2016 Chinese.
   Google Scholar
• Lähdesmäki H, Shmulevich I, Yli-Harja O. On learning gene regulatory networks under the boolean network model. Mach Learn. 2003;52(1–2):147–167. doi:10.1023/A:1023905711304
   Web of Science ®Google Scholar
• Dougherty J, Tabus I, Astola J. Inference of gene regulatory networks based on a universal minimum description length. EURASIP J Bioinform Syst Biol. 2008;(1):1–11.
   Google Scholar
• Liu W, Lähdesmäki H, Dougherty ER, Shmulevich I. Inference of boolean networks using sensitivity regularization. EURASIP J Bioinform Syst Biol. 2008;(1):780541.18604289
   PubMedGoogle Scholar
• Fang J, Ouyang H, Shen L, Dougherty ER, Liu W. Using the minimum description length principle to reduce the rate of false positives of best-fit algorithms. EURASIP J Bioinform Syst Biol. 2014;1:1–8.
   Google Scholar
• Madhamshettiwar PB, Maetschke SR, Davis MJ, Reverter A, Ragan MA. Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets. Genome Med. 2012;4(5):41. doi:10.1186/gm34022548828
   PubMed Web of Science ®Google Scholar
• Ahmed J, Meinel T, Dunkel M, et al. CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge. Nucleic Acids Res. 2011;39(Database issue):D960–7. doi:10.1093/nar/gkq91020952398
   PubMed Web of Science ®Google Scholar
• Barbarino JM, Whirl-Carrillo M, Altman RB, Klein TE. PharmGKB: a worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med. 2018;10(4):e1417. doi:10.1002/wsbm.141729474005
   PubMed Web of Science ®Google Scholar
• Shah OS, Chaudhary MFA, Awan HA, et al. ATLANTIS - attractor landscape analysis toolbox for cell fate discovery and reprogramming. Sci Rep. 2018;8(1):3554. doi:10.1038/s41598-018-22031-329476134
   PubMed Web of Science ®Google Scholar
• Glass L, Kauffman SA. The logical analysis of continuous, non-linear biochemical control networks. J Theor Biol. 1973;39(1):103–129. doi:10.1016/0022-5193(73)90208-74741704
   PubMed Web of Science ®Google Scholar
• Helikar T, Kochi N, Kowal B, et al. A comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells. PLoS One. 2013;8(4):e61757. doi:10.1371/journal.pone.006175723637902
   PubMed Web of Science ®Google Scholar
• Choi M, Shi J, Jung SH, Chen X, Cho KH. Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damage. Sci Signal. 2012;5(251):ra83. doi:10.1126/scisignal.200328923169817
   PubMed Web of Science ®Google Scholar
• Müssel C, Hopfensitz M, Kestler HA. BoolNet–an R package for generation, reconstruction and analysis of boolean networks. Bioinformatics. 2010;26(10):1378–1380. doi:10.1093/bioinformatics/btq12420378558
   PubMed Web of Science ®Google Scholar
• Longabaugh WJ, Davidson EH, Bolouri H. Computational representation of developmental genetic regulatory networks. Dev Biol. 2005;283(1):1–16. doi:10.1016/j.ydbio.2005.04.02315907831
   PubMed Web of Science ®Google Scholar
• Batagelij V, Mrvar A. Pajek- program for large network analysis. Connections. 1998;21(2):47–57.
   Google Scholar
• Shmulevich I, Dougherty ER, Kim S, Zhang W. Probabilistic boolean networks: a rule-based uncertainty model for gene-regulatory networks. Bioinformatics. 2002;18(2):261–274. doi:10.1093/bioinformatics/18.2.26111847074
   PubMed Web of Science ®Google Scholar
• Thomas R. Regulatory networks seen as asynchronous automata: a logical description. J Theor Biol. 1991;153(1):1–23. doi:10.1016/S0022-5193(05)80350-9
   Web of Science ®Google Scholar
• Sánchez L, Thieffry D. A logical analysis of the drosophila gap-gene system. J Theor Biol. 2001;211(2):115–141. doi:10.1006/jtbi.2001.233511419955
   PubMed Web of Science ®Google Scholar
• Sánchez L, Thieffry D. Segmenting the fly embryo: a logical analysis of the pair-rule cross-regulatory module. J Theor Biol. 2003;224(4):517–537. doi:10.1016/s0022-5193(03)00201-712957124
   PubMed Web of Science ®Google Scholar
• Zheng QB. Research on boolean network attractor determination algorithm [dissertation]. Zhejiang: University of Wen Zhou; 2015 Chinese.
   Google Scholar
• Hinkelmann F, Brandon M, Guang B, et al. ADAM: analysis of discrete models of biological systems using computer algebra. BMC Bioinformatics. 2011;12:295. doi:10.1186/1471-2105-12-29521774817
   PubMed Web of Science ®Google Scholar
• Waddington CH. The Strategy of Genes. London: Routledge; 1957.
   Google Scholar
• Kim Y, Choi S, Shin D, Cho KH. Quantitative evaluation and reversion analysis of the attractor landscapes of an intracellular regulatory network for colorectal cancer. BMC Syst Biol. 2017;11(1):45. doi:10.1186/s12918-017-0424-228381275
   PubMed Web of Science ®Google Scholar
• Tabus I, Astola J. On the use of MDL principle in gene expression prediction. EURASIP J Appl Signal Process. 2001;2001(4):297–303. doi:10.1155/S1110865701000270
   Google Scholar
• Vahedi G, Faryabi B, Chamberland JF, Datta A, Dougherty ER. Intervention in gene regulatory networks via a stationary mean-first-passage-time control policy. IEEE Trans Biomed Eng. 2008;55(10):2319–2331. doi:10.1109/TBME.2008.92567718838357
   PubMed Web of Science ®Google Scholar
• Qian X, Ivanov I, Ghaffari N, Dougherty ER. Intervention in gene regulatory networks via greedy control policies based on long-run behavior. BMC Syst Biol. 2009;3:61. doi:10.1186/1752-0509-3-4319527511
   PubMed Web of Science ®Google Scholar
• Yousefi MR, Dougherty ER. Intervention in gene regulatory networks with maximal phenotype alteration. Bioinformatics. 2013;29(14):1758–1767. doi:10.1093/bioinformatics/btt24223630177
   PubMed Web of Science ®Google Scholar
• Choi M, Shi J, Zhu Y, Yang R, Cho KH. Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response. Nat Commun. 2017;8(1):1940. doi:10.1038/s41467-017-02160-529208897
   PubMed Web of Science ®Google Scholar
• Fotis C, Antoranz A, Hatziavramidis D, Sakellaropoulos T, Alexopoulos LG. Pathway-based technologies for early drug discovery. Drug Discov Today. 2018;23(3):626–635. doi:10.1016/j.drudis.2017.12.00129294361
   PubMed Web of Science ®Google Scholar